4.5 Article

Glycemic control in non-diabetic critically ill patients

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.beem.2011.05.004

关键词

stress hyperglycemia; inpatient hyperglycemia; hospital hyperglycemia; ICU

资金

  1. American Diabetes Association [7-07-CR-56]
  2. NIH/NCRR [M01 RR-00039]
  3. Sanofi-Aventis
  4. Merck
  5. Glaxo Pharmaceuticals
  6. National Institute of Health [K08 DK0830361]

向作者/读者索取更多资源

Hyperglycemia is a common and costly health care problem in hospitalized patients. In hospital hyperglycemia is defined as any glucose value >7.8 mmol/l (140 mg/dl). Hyperglycemia is present in 40% of critically ill patients and in up to 80% of patients after cardiac surgery, with similar to 80% of ICU patients with hyperglycemia having no history of diabetes prior to admission. The risk of hospital complications relates to the severity of hyperglycemia, with a higher risk observed in patients without a history of diabetes compared to those with known diabetes. Improvement in glycemic control reduces hospital complications and mortality; however, the ideal glycemic target has not been determined. A target glucose level between 7.8 and 10.0 mmol/l (140 and 180 mg/dl) is recommended for the majority of ICU patients. This review aims to present updated recommendations for the inpatient management of hyperglycemia in critically ill patients with and without a history of diabetes. (C) 2011 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据